T, L., T, J., X, Y., C, L., J, S., Z, N., . . . Y, Y. (2016). Development of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancer in vitro and in vivo. Dove Medical Press.
Style de citation Chicago (17e éd.)T, Liu, Jia T, Yuan X, Liu C, Sun J, Ni Z, Xu J, Wang X, et Yuan Y. Development of Octreotide-conjugated Polymeric Prodrug of Bufalin for Targeted Delivery to Somatostatin Receptor 2 Overexpressing Breast Cancer in Vitro and in Vivo. Dove Medical Press, 2016.
Style de citation MLA (8e éd.)T, Liu, et al. Development of Octreotide-conjugated Polymeric Prodrug of Bufalin for Targeted Delivery to Somatostatin Receptor 2 Overexpressing Breast Cancer in Vitro and in Vivo. Dove Medical Press, 2016.
Attention : ces citations peuvent ne pas être correctes à 100%.